Rahmawaty Hasan (1), Burhanudin Gasim Soka (2), Saidah Saidah (3)
Guidelines for medication use during pregnancy must ensure that the therapeutic benefits significantly outweigh any short-term or long-term risks to both the mother and the fetus. This community service activity aimed to improve the understanding of 25 pregnant women in the Pematang Raya area, Simalungun Regency, North Sumatra, regarding the principles of safe medication use during pregnancy. The program applied an educational approach using informational media in the form of posters, combined with material presentation and interactive discussions. The activity began with a pre-test to assess participants’ baseline knowledge about medication use in pregnancy. Following the educational session, a post-test was conducted to evaluate the improvement in understanding. The results indicated a significant increase in knowledge, with 88% of respondents demonstrating a good understanding of safe medication principles during pregnancy. However, further evaluation is necessary for participants who did not fully comprehend the educational material to ensure overall program effectiveness.
Abdushshofi, R., Elvina, R., & Hersunaryati, Y. (2016). EVALUASI KETEPATAN PENGGUNAAN OBAT IBU HAMIL DI DEPARTEMEN OBSTETRI DAN GINEKOLOGI RUMAH SAKIT X. Farmasains.
Adhayanti, I., Pakadang, S. R., & Sukmawaty, M. (2025). CBIA (CARA BELAJAR IBU AKTIF) EDUKASI GOLONGAN OBAT DAN SWAMEDIKASI PENGGUNAAN OBAT PADA IBU HAMIL. Jurnal Mandala Pengabdian Masyarakat, 6(2), 886–892.
Astuti, I. A., Susanti, R., Nurparidah, & Mandiri, A. (2017). ASUHAN IBU DALAM MASA KEHAMILAN. Erlangga.
BKKBN (Badan Kependudukan dan Keluarga Berencana Nasional). (2025). LAPORAN KINERJA DIREKTORAT BINA PELAYANAN KELUARGA BERENCANA WILAYAH KHUSUS TAHUN 2024. BKKBN.
Direktorat Bina Farmasi Komunitas dan Klinik. (2006). PEDOMAN PELAYANAN FARMASI UNTUK IBU HAMIL DAN MENYUSUI. Departemen Kesehatan Republik Indonesia.
Nugraheni, G., Sulistyarini, A., & Zairina, E. (2020). BELIEFS ABOUT MEDICINES IN PREGNANCY: A SURVEY USING THE BELIEFS ABOUT MEDICINES QUESTIONNAIRE IN INDONESIA. International Journal of Clinical Pharmacy, 42, 57–64. https://doi.org/10.1007/s11096-019-00937-w
Twigg, M. J., Lupattelli, A., & Nordeng, H. (2016). WOMEN’S BELIEFS ABOUT MEDICATION USE DURING THEIR PREGNANCY: A UK PERSPECTIVE. International Journal of Clinical Pharmacy, 38, 968–976.
World Health Organization. (2016). WHO RECOMMENDATIONS ON ANTENATAL CARE FOR A POSITIVE PREGNANCY EXPERIENCE. World Health Organization.
Kementerian Kesehatan Republik Indonesia. (2020). PEDOMAN PELAYANAN ANTENATAL TERPADU. Kementerian Kesehatan RI.
Schaefer, C., Peters, P., & Miller, R. K. (2015). DRUGS DURING PREGNANCY AND LACTATION: TREATMENT OPTIONS AND RISK ASSESSMENT. Academic Press.
Briggs, G. G., Freeman, R. K., & Towers, C. V. (2017). DRUGS IN PREGNANCY AND LACTATION: A REFERENCE GUIDE TO FETAL AND NEONATAL RISK. Wolters Kluwer.
Alano, G. M., Ngougmna, E., Ostrea, E. M., Jr., & Konduri, G. G. (2013). PROLONGED USE OF OVER-THE-COUNTER MEDICATIONS DURING PREGNANCY. Clinical Pediatrics, 52(2), 145–150.
Lupattelli, A., Spigset, O., & Nordeng, H. (2014). ADHERENCE TO MEDICATIONS IN PREGNANCY: A CROSS-SECTIONAL, MULTINATIONAL WEB-BASED STUDY. BMJ Open, 4(2), e004402.
Sinclair, S. M., Miller, R. K., & Chambers, C. D. (2018). EVALUATING THE SAFETY OF MEDICATIONS USED DURING PREGNANCY. American Journal of Obstetrics & Gynecology, 218(6), 629–636.
Koren, G., & Nordeng, H. (2012). ANTIDEPRESSANT USE DURING PREGNANCY: THE BENEFIT–RISK RATIO. American Journal of Obstetrics & Gynecology, 207(3), 157–163.